In coronavirus disease 2019 (COVID-19), hypertension and cardiovascular diseases are
major risk factors for critical disease progression. However, the underlying causes and the …

Hepatitis C virus (HCV) is a major causative agent of chronic liver disease in humans. To gain
insight into host factor requirements for HCV replication, we performed a siRNA screen of …

Successful containment strategies for the SARS-CoV-2 pandemic will depend on reliable
diagnostic assays. Point-of-care antigen tests (POCT) may provide an alternative to time-…

Hepatitis B viruses (HBVs), which are enveloped viruses with reverse-transcribed DNA
genomes, constitute the family Hepadnaviridae. An outstanding feature of HBVs is their …

Since autumn 2020, rapid antigen tests (RATs) have been implemented in several countries
as an important pillar of the national testing strategy to rapidly screen for infections on site …

The Study of Health in Pomerania (SHIP) comprises the two independent cohorts SHIP-START
(recruited between 1997 and 2001) and SHIP-TREND (recruited between 2008 to 2012), …

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the
family Coronaviridae. The virus causes the infectious disease COVID-19. The biology of …

Changes in the airway microbiome may be important in the pathophysiology of chronic lung
disease in patients with cystic fibrosis. However, little is known about the microbiome in …

Virus infection-induced global protein synthesis suppression is linked to assembly of stress
granules (SGs), cytosolic aggregates of stalled translation preinitiation complexes. To study …

Background Sepsis and inflammation can cause intensive care unit‐acquired weakness (ICUAW).
Increased interleukin‐6 (IL‐6) plasma levels are a risk factor for ICUAW. IL‐6 …